Combining Pembrolizumab and Ofatumumab in Triple-Negative Breast Cancer and Multiple Sclerosis: A Case Report.

Iriyama H, Iwase M, Takano Y, Takeuchi D, Ichikawa T, Ohata R, Ozaki Y, Yamamoto M, Inaguma G, Torii N, Toyoda C, Kawabe K, Kikumori T, Masuda N

Open source

DOI: 10.70352/scrj.cr.26-0383
Published: 2026
Container: Surgical case reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.70352/scrj.cr.26-0383,
  title = {Combining Pembrolizumab and Ofatumumab in Triple-Negative Breast Cancer and Multiple Sclerosis: A Case Report.},
  author = {Iriyama H and Iwase M and Takano Y and Takeuchi D and Ichikawa T and Ohata R and Ozaki Y and Yamamoto M and Inaguma G and Torii N and Toyoda C and Kawabe K and Kikumori T and Masuda N},
  year = {2026},
  journal = {Surgical case reports},
  doi = {10.70352/scrj.cr.26-0383},
  url = {https://doi.org/10.70352/scrj.cr.26-0383}
}

RIS

TY  - JOUR
TI  - Combining Pembrolizumab and Ofatumumab in Triple-Negative Breast Cancer and Multiple Sclerosis: A Case Report.
AU  - Iriyama H
AU  - Iwase M
AU  - Takano Y
AU  - Takeuchi D
AU  - Ichikawa T
AU  - Ohata R
AU  - Ozaki Y
AU  - Yamamoto M
AU  - Inaguma G
AU  - Torii N
AU  - Toyoda C
AU  - Kawabe K
AU  - Kikumori T
AU  - Masuda N
PY  - 2026
JO  - Surgical case reports
DO  - 10.70352/scrj.cr.26-0383
UR  - https://doi.org/10.70352/scrj.cr.26-0383
ER  -

APA

H, I., M, I., Y, T., D, T., T, I., R, O., Y, O., M, Y., G, I., N, T., C, T., K, K., T, K., & N, M. (2026). Combining Pembrolizumab and Ofatumumab in Triple-Negative Breast Cancer and Multiple Sclerosis: A Case Report.. Surgical case reports. https://doi.org/10.70352/scrj.cr.26-0383

Source records

pubmed · retrieved 2026-09-26T03:24:26.168Z
europe-pmc · retrieved 2026-09-26T03:24:26.156Z